ロード中...
LPS-induced NFκB enhanceosome requires TonEBP/NFAT5 without DNA binding
NFκB is a central mediator of inflammation. Present inhibitors of NFκB are mostly based on inhibition of essential machinery such as proteasome and protein kinases, or activation of nuclear receptors; as such, they are of limited therapeutic use due to severe toxicity. Here we report an LPS-induced...
保存先:
| 出版年: | Sci Rep |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4847014/ https://ncbi.nlm.nih.gov/pubmed/27118681 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep24921 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|